Help Us Make a Difference
Neglected tropical and infectious diseases receive limited investments from the global community, yet 90% of people are afflicted by them. You can help us make a difference.
30 theatrical performances were conducted in cooperation with a local non-governmental organization between December 2008 and February 2009 in a kala-azar endemic district of Bihar, India. The initiative aimed to educate community members of their individual and collective vulnerability to kala-azar, and stress the importance of early diagnosis, available treatment options, and need for treatment compliance.
The Global Challenge
Soil-transmitted helminths (STH) infections are highly endemic in tropical and subtropical areas of sub-Saharan Africa, Asia, and Latin America. It is estimated that approximately 2 billion people (nearly one-third of the world's population) have active STH infections. STH have remained largely neglected by the global health community because the people most affected are among the most impoverished and because the infection causes chronic ill health with insidious clinical presentations, rather than severe acute illness or high incidence of death. It is common for a single individual, especially a child, to be infected chronically with all three types of STH.
Our program works to improve diagnosis of helminths in South Asia, where the infections are endemic. We have established collaborations with researchers at the Swiss Tropical Institute and the University of California, San Diego, to evaluate potential new anthelmintic drug candidates. We have also conducted clinical capacity building and epidemiology training at selected sites in India. The training assured that participants are now better equipped to conduct epidemiological studies.
In 2011, we expanded our work to Vietnam, where diagnosing helminth infections poses a significant public health challenge. Working with our partners, we trained health workers and provided microscopes and other equipment to help expand laboratory capacity and ensure accurate diagnosis of helminth infections in both research and clinical settings.
Most recently, we joined the Jharkhand State Department of Health's initiative to reduce chronic worm infection, especially among children, in India. We provided support to train health workers, determine infection prevalence in rural areas, and develop strategies to improve communities' health and hygiene and reduce the spread of intestinal worms.
PDP Access Steering Committee Papers
PDP Pricing Discussion Paper. Boulton, I. 2010. The PDP Steering Committee's review of pricing strategies currently being used by PDPs.
Access to New Health Products in Low Income Countries and the Challenge of Pharmacovigilance. Lalvani, P. and Milstein, J. 2011. The PDP Steering Committee’s review of pharmacovigilance strategies currently being used by PDPs.
PDP Manufacturing And Supply Strategies. Davies, N. and Mertenskoetter, T. 2011. The PDP Steering Committee’s review of manufacturing and supply strategies currently being used by PDPs.
PDP Economics and Financing Discussion Paper. Jones, A. 2010.
PDP Access Strategy Discussion Paper Herman, L. and Oudin, A. October 2010.
PDP Regulatory Discussion Paper: Regulatory challenges in ensuring equitable access to new health products in low income countries. Milstien, J. and Brennan, M. 2010. The PDP Steering Committee’s review of regulatory strategies currently being used by PDPs.
For more information on the work of the PDP Access group, please visit www.pdpaccess.org.